Largest Biotechnology Companies by Market Cap
Largest Biotechnology companies by market cap. The Biotechnology sector has 1,295 publicly listed stocks with a combined market cap of $2.06 Trillion. Vyne Therapeutics Inc leads the sector with a market cap of $22.03 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Biotechnology Stocks by Market Capitalization (November 2026)
Top Biotechnology stocks by market capitalization as of November 2026, covering 1,295 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 901 |
Vyne Therapeutics Inc
NASDAQ:VYNE |
$22.03 Million | $22.03 Million | USA | $30.45 | +8.56% | +3311.00% | 39.60 Million |
| 902 |
Elevation Oncology Inc
NASDAQ:ELEV |
$21.63 Million | $21.63 Million | USA | $0.37 | +0.00% | +0.00% | 4.82 Million |
| 903 |
NanoViricides Inc
NYSE MKT:NNVC |
$21.57 Million | $21.57 Million | USA | $1.64 | +5.81% | -5.75% | 10.62 Million |
| 904 |
Seoulin Bioscience Co.Ltd
KQ:038070 |
$21.33 Million | ₩31.47 Billion | Korea | ₩3565.00 | -1.11% | -5.44% | 867.01K |
| 905 |
Gensight Biologics SA
PA:SIGHT |
$21.16 Million | €18.10 Million | France | €0.08 | +3.90% | +5.18% | 35.67 Million |
| 906 |
Genolution Inc.
KQ:225220 |
$21.11 Million | ₩31.15 Billion | Korea | ₩1724.00 | +0.23% | +6.42% | 1.05 Million |
| 907 |
Nanogroup SA
WAR:NNG |
$20.80 Million | zł75.59 Million | Poland | zł2.35 | +0.00% | +0.43% | 456.91K |
| 908 |
VACCITECH (SP.ADR)/1
F:2AB |
$20.62 Million | €17.64 Million | Germany | €0.51 | +5.65% | +10.26% | 6.00K |
| 909 |
GridAI Technologies Corp.
NASDAQ:GRDX |
$20.40 Million | $20.40 Million | USA | $4.96 | -8.99% | -9.65% | 2.68 Million |
| 910 |
Mgenplus Co. Ltd.
KQ:032790 |
$20.36 Million | ₩30.05 Billion | Korea | ₩1170.00 | -3.54% | -1.18% | 1.74 Million |
| 911 |
Biomind Labs Inc
NEO:BMND |
$19.92 Million | CA$27.54 Million | Canada | CA$0.36 | -48.55% | -38.79% | 102.38K |
| 912 |
Matricelf Ltd
TA:MTLF |
$19.61 Million | ILA7.31 Billion | Israel | ILA250.10 | +1.87% | +1.01% | 1.44 Million |
| 913 |
Neurotech International Ltd
AU:NTI |
$19.44 Million | AU$27.47 Million | Australia | AU$0.02 | +0.00% | -5.56% | 138.73 Million |
| 914 |
Cocrystal Pharma Inc
NASDAQ:COCP |
$19.17 Million | $19.17 Million | USA | $1.00 | +1.53% | +9.10% | 939.43K |
| 915 |
IRLAB Therapeutics AB (publ)
ST:IRLAB-A |
$19.09 Million | Skr177.35 Million | Sweden | Skr2.09 | -1.42% | +5.45% | 18.69 Million |
| 916 |
SynCore Biotechnology Co Ltd
TWO:4192 |
$18.72 Million | NT$594.29 Million | Taiwan | NT$16.90 | +2.42% | -3.15% | 376.03K |
| 917 |
Medivir AB
ST:MVIR |
$18.71 Million | Skr173.86 Million | Sweden | Skr1.55 | -3.73% | +3.33% | 28.76 Million |
| 918 |
Atossa Genetics Inc
NASDAQ:ATOS |
$18.69 Million | $18.69 Million | USA | $2.17 | -2.69% | -20.22% | 2.22 Million |
| 919 |
Resverlogix Corp.
TO:RVX |
$18.68 Million | CA$25.82 Million | Canada | CA$0.08 | -6.25% | -11.76% | 653.04K |
| 920 |
Genus PLC
LSE:GNS |
$18.62 Million | GBX153.05 Billion | UK | GBX2304.50 | +0.25% | +2.88% | 5.36 Million |
| 921 |
Sensei Biotherapeutics Inc
NASDAQ:SNSE |
$18.59 Million | $18.59 Million | USA | $25.96 | -28.23% | +78.66% | 1.90 Million |
| 922 |
Kyntra Bio, Inc.
NASDAQ:KYNB |
$18.50 Million | $18.50 Million | USA | $4.57 | -1.72% | -12.45% | 570.08K |
| 923 |
Serina Therapeutics Inc
NYSE MKT:SER |
$17.80 Million | $17.80 Million | USA | $1.98 | +4.93% | +15.12% | 1.95 Million |
| 924 |
Seres Therapeutics Inc
NASDAQ:MCRB |
$17.78 Million | $17.78 Million | USA | $1.77 | -9.23% | -16.90% | 2.01 Million |
| 925 |
Simris Alg AB (publ)
ST:SIMRIS-B |
$17.58 Million | Skr163.32 Million | Sweden | Skr0.12 | -3.20% | +2.11% | 5.11 Million |
| 926 |
Context Therapeutics Inc
NASDAQ:CNTX |
$17.37 Million | $17.37 Million | USA | $0.19 | -6.25% | -19.74% | 25.64 Million |
| 927 |
Jasper Therapeutics Inc
NASDAQ:JSPR |
$17.31 Million | $17.31 Million | USA | $0.52 | -2.22% | +4.96% | 10.10 Million |
| 928 |
Urteste SA
WAR:URT |
$17.22 Million | zł62.57 Million | Poland | zł41.00 | -2.38% | -0.97% | 15.24K |
| 929 |
Take Solutions Limited
NSE:TAKE |
$16.86 Million | Rs1.56 Billion | India | Rs10.66 | -3.62% | -7.30% | 11.42 Million |
| 930 |
Neuphoria Therapeutics Inc
NASDAQ:NEUP |
$16.50 Million | $16.50 Million | USA | $3.05 | -0.33% | -12.36% | 617.05K |
| 931 |
Genenta Science SpA ADR
NASDAQ:GNTA |
$16.45 Million | $16.45 Million | USA | $0.70 | -1.69% | -1.63% | 2.38 Million |
| 932 |
Marker Therapeutics Inc
NASDAQ:MRKR |
$16.34 Million | $16.34 Million | USA | $0.98 | -2.97% | -8.41% | 4.04 Million |
| 933 |
Diamyd Medical AB (publ)
ST:DMYD-B |
$16.24 Million | Skr150.88 Million | Sweden | Skr1.00 | -0.80% | -1.39% | 14.63 Million |
| 934 |
Hoth Therapeutics Inc
NASDAQ:HOTH |
$15.67 Million | $15.67 Million | USA | $0.82 | -7.93% | -36.49% | 522.03 Million |
| 935 |
Radiopharm Theranostics Limited American Depositary Shares
NASDAQ:RADX |
$15.62 Million | $15.62 Million | USA | $1.08 | -3.26% | +13.68% | 1.09 Million |
| 936 |
Scisparc Ltd
NASDAQ:SPRC |
$15.60 Million | $15.60 Million | USA | $0.68 | -5.05% | -43.64% | 78.56 Million |
| 937 |
Radiopharm Theranostics Ltd
AU:RAD |
$15.49 Million | AU$21.89 Million | Australia | AU$0.01 | +25.00% | +25.00% | 155.20 Million |
| 938 |
Defence Therapeutics Inc.
F:DTC |
$15.43 Million | €13.20 Million | Germany | €0.23 | +1.32% | -2.95% | 296.74K |
| 939 |
Quantum BioPharma Ltd.
NASDAQ:QNTM |
$15.30 Million | $15.30 Million | USA | $2.38 | -2.46% | +4.85% | 3.22 Million |
| 940 |
CHEMOMAB THERAP. ADR/20
F:2QV0 |
$15.26 Million | €13.05 Million | Germany | €2.94 | +300.00% | +269.81% | 30.70K |
| 941 |
Acumen Pharmaceuticals Inc
NASDAQ:ABOS |
$15.18 Million | $15.18 Million | USA | $0.21 | -90.83% | -89.80% | 80.32 Million |
| 942 |
Neurosense Therapeutics Ltd
NASDAQ:NRSN |
$15.14 Million | $15.14 Million | USA | $1.99 | -6.57% | -18.44% | 612.33K |
| 943 |
Devonian Health Group Inc
V:GSD |
$15.09 Million | CA$20.86 Million | Canada | CA$7.50 | +11.11% | -6.25% | 96.73K |
| 944 |
Karyopharm Therapeutics Inc
NASDAQ:KPTI |
$15.00 Million | $15.00 Million | USA | $0.66 | -24.76% | +21.22% | 100.95 Million |
| 945 |
Pluri Inc.
NASDAQ:PLUR |
$14.87 Million | $14.87 Million | USA | $1.24 | +3.33% | +22.77% | 1.22 Million |
| 946 |
Applied Therapeutics Inc
NASDAQ:APLT |
$14.86 Million | $14.86 Million | USA | $0.10 | +0.00% | +6.96% | 245.46 Million |
| 947 |
Zivo Bioscience Inc
NASDAQ:ZIVO |
$14.59 Million | $14.59 Million | USA | $3.52 | -14.27% | -2.36% | 6.79K |
| 948 |
Pharma Equity Group A/S Cl A
CO:PEG |
$14.40 Million | Dkr92.07 Million | Denmark | Dkr0.08 | -3.85% | -5.30% | 12.02 Million |
| 949 |
Citius Pharmaceuticals Inc
NASDAQ:CTXR |
$14.36 Million | $14.36 Million | USA | $0.52 | -7.10% | +41.07% | 5.94 Million |
| 950 |
Initiator Pharma A/S
ST:INIT |
$14.33 Million | Skr133.14 Million | Sweden | Skr1.95 | -6.94% | -13.17% | 3.68 Million |
| 951 |
Algorae Pharmaceuticals Ltd
AU:1AI |
$14.31 Million | AU$20.23 Million | Australia | AU$0.01 | +0.00% | +0.00% | 19.13 Million |
| 952 |
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC |
$14.25 Million | $14.25 Million | USA | $6.37 | +0.00% | +0.00% | 220.50K |
| 953 |
GENENTA SCIENCE(SP.ADR)/1
F:K5F |
$14.25 Million | €12.18 Million | Germany | €0.52 | +0.00% | +10.17% | 15.96K |
| 954 |
PROBIOTIX HEALTH LS-05
F:X90 |
$14.24 Million | €12.18 Million | Germany | €0.08 | +0.65% | +0.65% | 0.00 |
| 955 |
Daesung Microbiological Labs. Co. Ltd
KQ:036480 |
$14.14 Million | ₩20.86 Billion | Korea | ₩5490.00 | -0.54% | -1.96% | 98.84K |
| 956 |
Proteomics International Laboratories Ltd
AU:PIQ |
$14.03 Million | AU$19.82 Million | Australia | AU$0.12 | +2.13% | +4.35% | 2.29 Million |
| 957 |
Botanix Pharmaceuticals Ltd
AU:BOT |
$13.94 Million | AU$19.71 Million | Australia | AU$0.01 | -16.67% | -23.08% | 240.25 Million |
| 958 |
COCRYSTAL PHARMA NEW O.N.
F:8CC |
$13.94 Million | €11.92 Million | Germany | €0.87 | +1.17% | +6.13% | 0.00 |
| 959 |
Elicera Therapeutics AB
ST:ELIC |
$13.87 Million | Skr128.86 Million | Sweden | Skr2.66 | -3.10% | -5.18% | 4.73 Million |
| 960 |
Dyadic International Inc
NASDAQ:DYAI |
$13.76 Million | $13.76 Million | USA | $0.38 | +5.32% | -5.42% | 2.41 Million |
| 961 |
ABERA BIOSCIENCE AB
F:8WK |
$13.66 Million | €11.68 Million | Germany | €0.57 | -0.70% | +0.35% | 0.00 |
| 962 |
Biotechnology Assets S.A.
MC:BST |
$13.52 Million | €11.57 Million | Spain | €0.18 | -4.21% | -0.27% | 3.75 Million |
| 963 |
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB |
$13.52 Million | $13.52 Million | USA | $0.33 | -0.15% | -15.00% | 3.90K |
| 964 |
Allarity Therapeutics Inc
NASDAQ:ALLR |
$13.46 Million | $13.46 Million | USA | $0.87 | -2.20% | +2.81% | 2.96 Million |
| 965 |
Biocardia Inc
NASDAQ:BCDA |
$13.03 Million | $13.03 Million | USA | $0.86 | -7.02% | -7.29% | 2.98 Million |
| 966 |
Medifron DBT Co. Ltd
KQ:065650 |
$13.02 Million | ₩19.22 Billion | Korea | ₩1444.00 | -0.41% | -25.99% | 7.69 Million |
| 967 |
Moleculin Biotech Inc
NASDAQ:MBRX |
$13.02 Million | $13.02 Million | USA | $7.90 | -9.40% | +34.13% | 9.16 Million |
| 968 |
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ:CVKD |
$12.93 Million | $12.93 Million | USA | $5.53 | -5.63% | +14.97% | 1.28 Million |
| 969 |
Cerenome, Inc.
NASDAQ:CNSY |
$12.90 Million | $12.90 Million | USA | $1.70 | -2.30% | -2.86% | 3.51 Million |
| 970 |
BTC Health Ltd
AU:BTC |
$12.90 Million | AU$18.23 Million | Australia | AU$0.05 | +0.00% | -8.93% | 1.74 Million |
| 971 |
GENFLOW BIOSCIENCES PLC
F:WQ5 |
$12.84 Million | €10.98 Million | Germany | €0.02 | +0.00% | +2.50% | 0.00 |
| 972 |
Neuroscientific Biopharmaceuticals Ltd
AU:NSB |
$12.71 Million | AU$17.96 Million | Australia | AU$0.05 | +3.85% | -10.00% | 2.90 Million |
| 973 |
Vyome Holdings, Inc.
NASDAQ:HIND |
$12.63 Million | $12.63 Million | USA | $1.80 | +2.86% | +0.00% | 261.94K |
| 974 |
Imugene Ltd
AU:IMU |
$12.34 Million | AU$17.43 Million | Australia | AU$0.04 | -7.89% | -10.26% | 85.41 Million |
| 975 |
Biovie Inc
NASDAQ:BIVI |
$12.09 Million | $12.09 Million | USA | $1.43 | +3.62% | +11.72% | 4.26 Million |
| 976 |
CEL-SCI Corp
NYSE MKT:CVM |
$12.01 Million | $12.01 Million | USA | $1.42 | -2.07% | +9.23% | 17.92 Million |
| 977 |
Lipocine Inc
NASDAQ:LPCN |
$11.87 Million | $11.87 Million | USA | $1.44 | -5.26% | -1.37% | 112.95 Million |
| 978 |
Xintela AB
ST:XINT |
$11.81 Million | Skr109.72 Million | Sweden | Skr0.16 | -0.95% | -11.86% | 5.15 Million |
| 979 |
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI |
$11.73 Million | $11.73 Million | USA | $1.06 | -1.60% | -0.68% | 559.25K |
| 980 |
Aelis Farma SA
PA:AELIS |
$11.52 Million | €9.86 Million | France | €0.72 | -2.30% | +0.70% | 356.01K |
| 981 |
Hookipa Pharma Inc
NASDAQ:HOOK |
$11.47 Million | $11.47 Million | USA | $1.15 | +0.00% | +0.00% | 48.02K |
| 982 |
Active Biotech AB
ST:ACTI |
$11.33 Million | Skr105.31 Million | Sweden | Skr4.00 | +4.44% | +26.03% | 1.37 Million |
| 983 |
Sirona Biochem Corp
V:SBM |
$11.23 Million | CA$15.53 Million | Canada | CA$0.06 | +0.00% | +0.00% | 0.00 |
| 984 |
Polyrizon Ltd. Ordinary Shares
NASDAQ:PLRZ |
$11.20 Million | $11.20 Million | USA | $10.75 | +19.40% | +23.27% | 541.23K |
| 985 |
Adial Pharmaceuticals Inc
NASDAQ:ADIL |
$11.18 Million | $11.18 Million | USA | $3.81 | -21.93% | -9.72% | 1.08 Million |
| 986 |
Passage Bio Inc
NASDAQ:PASG |
$11.10 Million | $11.10 Million | USA | $3.45 | -1.99% | -1.71% | 410.64K |
| 987 |
Scancell Hldgs Plc
LSE:SCLP |
$11.04 Million | GBX90.70 Billion | UK | GBX87.40 | -1.80% | -3.96% | 21.01 Million |
| 988 |
Lisata Therapeutics Inc.
NASDAQ:LSTA |
$11.02 Million | $11.02 Million | USA | $1.02 | +0.99% | +1.49% | 2.42 Million |
| 989 |
Advicenne
PA:ALDVI |
$11.01 Million | €9.41 Million | France | €0.65 | -6.23% | +2.70% | 681.90K |
| 990 |
Portage Biotech Inc
NASDAQ:PRTG |
$10.71 Million | $10.71 Million | USA | $4.70 | -0.84% | +0.00% | 157.79K |
| 991 |
Tscan Therapeutics Inc
NASDAQ:TCRX |
$10.66 Million | $10.66 Million | USA | $0.17 | -10.47% | -19.29% | 13.53 Million |
| 992 |
Noxopharm Ltd
AU:NOX |
$10.65 Million | AU$15.05 Million | Australia | AU$0.05 | +0.00% | -10.91% | 1.18 Million |
| 993 |
Biovica International AB (publ)
ST:BIOVIC-B |
$10.64 Million | Skr98.83 Million | Sweden | Skr0.36 | -3.23% | +18.09% | 6.39 Million |
| 994 |
Tvardi Therapeutics, Inc.
NASDAQ:TVRD |
$10.58 Million | $10.58 Million | USA | $0.79 | -8.13% | -18.45% | 3.68 Million |
| 995 |
Argenica Therapeutics Ltd
AU:AGN |
$10.45 Million | AU$14.77 Million | Australia | AU$0.12 | +9.52% | +4.55% | 1.30 Million |
| 996 |
TME PHARM.CONF.IPO EO 1-
F:0N6A |
$10.44 Million | €8.93 Million | Germany | €0.13 | +27.20% | +16.48% | 0.00 |
| 997 |
Poxel SA
PA:POXEL |
$10.36 Million | €8.87 Million | France | €0.17 | -3.62% | -11.37% | 26.04 Million |
| 998 |
Dare Bioscience Inc
NASDAQ:DARE |
$10.19 Million | $10.19 Million | USA | $0.70 | +2.66% | +7.35% | 3.95 Million |
| 999 |
EZZ Life Science Holdings Ltd
AU:EZZ |
$10.15 Million | AU$14.35 Million | Australia | AU$0.31 | -1.61% | -4.69% | 398.57K |
| 1000 |
GlycoMimetics Inc
NASDAQ:GLYC |
$10.13 Million | $10.13 Million | USA | $0.16 | +0.00% | +0.00% | 1.07 Million |
| 1001 |
BioRestorative Therapies Inc
NASDAQ:BRTX |
$10.05 Million | $10.05 Million | USA | $1.40 | -11.37% | -6.65% | 921.38K |
| 1002 |
Phio Pharmaceuticals Corp
NASDAQ:PHIO |
$9.99 Million | $9.99 Million | USA | $0.86 | -0.30% | -1.43% | 1.83 Million |
| 1003 |
CalciMedica, Inc. Common Stock
NASDAQ:CALC |
$9.90 Million | $9.90 Million | USA | $1.46 | -16.57% | +26.96% | 1.80 Million |
| 1004 |
Shenzhen CAU Technology Co Ltd
SHE:000004 |
$9.88 Million | CN¥67.51 Million | China | CN¥0.51 | +10.87% | +13.33% | 151.25 Million |
| 1005 |
SeaStar Medical Holding Corporation
NASDAQ:ICU |
$9.87 Million | $9.87 Million | USA | $2.24 | -3.03% | -21.40% | 5.73 Million |
| 1006 |
Orgenesis Inc
NASDAQ:ORGS |
$9.83 Million | $9.83 Million | USA | $1.95 | +0.00% | +0.00% | 2.56K |
| 1007 |
Opthea Ltd
AU:OPT |
$9.68 Million | AU$13.68 Million | Australia | AU$0.01 | -9.09% | -16.67% | 127.63 Million |
| 1008 |
BioLineRx Ltd
NASDAQ:BLRX |
$9.65 Million | $9.65 Million | USA | $1.99 | -1.49% | -3.56% | 331.38K |
| 1009 |
Clal Biotechnology Industries Ltd
TA:CBI |
$9.63 Million | ILA3.59 Billion | Israel | ILA22.90 | +0.88% | -2.55% | 2.17 Million |
| 1010 |
GT Biopharma Inc
NASDAQ:GTBP |
$9.60 Million | $9.60 Million | USA | $5.32 | -5.00% | -3.62% | 1.35 Million |
| 1011 |
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ:GDTC |
$9.58 Million | $9.58 Million | USA | $0.92 | +2.02% | -0.02% | 418.80K |
| 1012 |
Entero Therapeutics, Inc.
NASDAQ:ENTO |
$9.58 Million | $9.58 Million | USA | $2.85 | -5.32% | -13.11% | 3.88 Million |
| 1013 |
Adaptimmune Therapeutics Plc
NASDAQ:ADAP |
$9.54 Million | $9.54 Million | USA | $0.04 | +0.00% | +0.00% | 5.71 Million |
| 1014 |
Zhuhai Sailong Pharmaceutical Co Ltd
SHE:002898 |
$9.53 Million | CN¥65.12 Million | China | CN¥0.37 | -2.63% | +8.82% | 140.79 Million |
| 1015 |
ESSA Pharma Inc
NASDAQ:EPIX |
$9.52 Million | $9.52 Million | USA | $0.20 | +0.00% | +0.00% | 5.95 Million |
| 1016 |
Intensity Therapeutics, Inc. Common stock
NASDAQ:INTS |
$9.19 Million | $9.19 Million | USA | $3.40 | +1.80% | +6.58% | 489.34K |
| 1017 |
Immuron Ltd
AU:IMC |
$9.15 Million | AU$12.93 Million | Australia | AU$0.04 | +0.00% | +0.00% | 4.98 Million |
| 1018 |
Quoin Pharmaceuticals Ltd DRC
NASDAQ:QNRX |
$9.12 Million | $9.12 Million | USA | $4.54 | +9.40% | +13.22% | 880.29K |
| 1019 |
Pharmena S.A.
WAR:PHR |
$9.07 Million | zł32.97 Million | Poland | zł2.96 | -0.67% | -1.00% | 29.53K |
| 1020 |
AEON Biopharma, Inc.
NYSE MKT:AEON |
$9.05 Million | $9.05 Million | USA | $0.78 | -5.38% | -3.00% | 1.85 Million |
| 1021 |
Bolt Biotherapeutics
NASDAQ:BOLT |
$8.97 Million | $8.97 Million | USA | $6.59 | +3.62% | +57.28% | 14.31 Million |
| 1022 |
Celyad SA
BR:CYAD |
$8.95 Million | €7.66 Million | Belgium | €0.20 | -4.76% | -3.85% | 222.26K |
| 1023 |
Chromocell Therapeutics Corporation
NYSE MKT:CHRO |
$8.90 Million | $8.90 Million | USA | $22.46 | +0.00% | +0.00% | 4.72K |
| 1024 |
Palatin Technologies, Inc. Common Stock
NASDAQ:PTN |
$8.90 Million | $8.90 Million | USA | $5.00 | +1.42% | -9.26% | 770.30K |
| 1025 |
OPTHEA LTD
F:UKJ |
$8.89 Million | €7.61 Million | Germany | €0.01 | +1.75% | -17.14% | 0.00 |
| 1026 |
In8bio Inc
NASDAQ:INAB |
$8.89 Million | $8.89 Million | USA | $0.90 | -8.04% | -8.58% | 994.72K |
| 1027 |
XTL Biopharmaceuticals Ltd ADR
NASDAQ:XTLB |
$8.80 Million | $8.80 Million | USA | $2.45 | -2.59% | +2.73% | 282.27K |
| 1028 |
Scandinavian ChemoTech AB Series B
ST:CMOTEC-B |
$8.71 Million | Skr80.93 Million | Sweden | Skr3.40 | +5.92% | -7.36% | 219.87K |
| 1029 |
COSCIENS Biopharma Inc.
NASDAQ:CSCI |
$8.64 Million | $8.64 Million | USA | $7.65 | +0.53% | +4.79% | 25.29K |
| 1030 |
Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN |
$8.60 Million | $8.60 Million | USA | $1.26 | -59.35% | -72.31% | 26.05 Million |
| 1031 |
BioLine RX Ltd
TA:BLRX |
$8.58 Million | ILA3.20 Billion | Israel | ILA1.10 | +0.00% | +0.00% | 89.51 Million |
| 1032 |
Chemomab Therapeutics Ltd DRC
NASDAQ:CMMB |
$8.50 Million | $8.50 Million | USA | $1.16 | +6.42% | +7.41% | 2.11 Million |
| 1033 |
Lantern Pharma Inc
NASDAQ:LTRN |
$8.45 Million | $8.45 Million | USA | $0.66 | -9.60% | +3.14% | 7.56 Million |
| 1034 |
Pasithea Therapeutics Corp
NASDAQ:KTTA |
$8.29 Million | $8.29 Million | USA | $0.37 | +0.16% | -16.85% | 6.71 Million |
| 1035 |
Turnstone Biologics Corp. Common Stock
NASDAQ:TSBX |
$8.21 Million | $8.21 Million | USA | $0.36 | +0.00% | +0.00% | 0.00 |
| 1036 |
Tempest Therapeutics Inc
NASDAQ:TPST |
$8.20 Million | $8.20 Million | USA | $0.50 | -7.07% | -5.13% | 5.87 Million |
| 1037 |
Ensysce Biosciences Inc
NASDAQ:ENSC |
$8.19 Million | $8.19 Million | USA | $0.42 | -3.88% | -17.61% | 12.34 Million |
| 1038 |
Hemostemix Inc
V:HEM |
$8.18 Million | CA$11.31 Million | Canada | CA$0.06 | +0.00% | +9.09% | 1.02 Million |
| 1039 |
Synaptogenix Inc
NASDAQ:SNPX |
$8.09 Million | $8.09 Million | USA | $5.82 | +0.00% | +0.00% | 424.16K |
| 1040 |
LISATA THERAP.INC.DL-001
F:8NE |
$8.06 Million | €6.90 Million | Germany | €0.80 | -0.62% | -7.51% | 0.00 |
| 1041 |
Curanex Pharmaceuticals Inc Common Stock
NASDAQ:CURX |
$7.99 Million | $7.99 Million | USA | $5.16 | +4.45% | -0.77% | 462.76K |
| 1042 |
Oxford BioMedica PLC
LSE:OXB |
$7.92 Million | GBX65.09 Billion | UK | GBX539.00 | +1.32% | +5.48% | 6.68 Million |
| 1043 |
Ascelia Pharma AB (publ)
ST:ACE |
$7.92 Million | Skr73.58 Million | Sweden | Skr0.58 | +0.00% | +13.73% | 32.70 Million |
| 1044 |
Visgeneer
TWO:4197 |
$7.90 Million | NT$250.80 Million | Taiwan | NT$8.31 | +0.00% | -3.93% | 963.56K |
| 1045 |
GRAFT POLYMER UK LS -001
F:J4I |
$7.90 Million | €6.76 Million | Germany | €0.00 | +0.00% | +0.00% | 0.00 |
| 1046 |
Collplant Biotechnologies Ltd
NASDAQ:CLGN |
$7.88 Million | $7.88 Million | USA | $4.14 | -6.02% | +14.23% | 1.11 Million |
| 1047 |
Theriva Biologics Inc.
NYSE MKT:TOVX |
$7.82 Million | $7.82 Million | USA | $0.17 | -8.82% | -10.26% | 12.87 Million |
| 1048 |
Actuate Therapeutics, Inc. Common stock
NASDAQ:ACTU |
$7.79 Million | $7.79 Million | USA | $0.34 | -9.68% | -35.08% | 11.94 Million |
| 1049 |
Bergenbio ASA
OL:BGBIO |
$7.75 Million | Nkr73.62 Million | Norway | Nkr0.47 | -5.91% | -61.29% | 11.24 Million |
| 1050 |
Soligenix Inc.
NASDAQ:SNGX |
$7.75 Million | $7.75 Million | USA | $0.36 | -3.63% | -2.36% | 2.90 Million |
How Biotechnology Companies Are Ranked by Market Cap
Biotechnology companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries